CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
focused on patients who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come bac...
Phase 3
Taipei City, Taiwan and 60 other locations
of CHO-H01 in subjects with relapsed/refractory CD20+ non-Hodgkin's lymphoma. It will also determine maximum tolerated dose (MTD) and recomm...
Phase 1, Phase 2
Taipei, Taiwan and 7 other locations
The primary objective of this study is to determine the recommended dosing regimen of loncastuximab tesirine in diffuse large B-cell lymphoma...
Phase 1
Taipei, Taiwan and 12 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Taipei, Taiwan and 59 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Taipei City, Taiwan and 93 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Taipei, Taiwan and 66 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Taipei, Taiwan and 215 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-0201 in adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma...
Phase 1
Taipei, Taiwan and 7 other locations
or obinutuzumab) in subjects with relapsed or refractory (R/R) lymphoma. Subjects must have received at least 2 prior lines of therapy, and ...
Phase 1
Taoyuan City, Taiwan and 25 other locations
safety, and tolerability BGB-3111 plus obinutuzumab versus obinutuzumab alone in participants with relapsed/refractory non-Hodgkin follicular lymphoma...
Phase 2
Taipei, Taiwan and 119 other locations
Clinical trials
Research sites
Resources
Legal